Table 3.
Control group (n=55) | Research group (n=61) | t/X2 | P | |
---|---|---|---|---|
Rash | 1 (1.82) | 2 (3.28) | ||
Nausea | 1 (1.82) | 3 (4.92) | ||
Diarrhea | 0 (0.00) | 1 (1.64) | ||
Constipation | 2 (3.64) | 1 (1.64) | ||
Total adverse reactions | 4 (7.27) | 7 (11.48) | 0.595 | 0.440 |
Control group (n=55) | Research group (n=61) | t/X2 | P | |
---|---|---|---|---|
Rash | 1 (1.82) | 2 (3.28) | ||
Nausea | 1 (1.82) | 3 (4.92) | ||
Diarrhea | 0 (0.00) | 1 (1.64) | ||
Constipation | 2 (3.64) | 1 (1.64) | ||
Total adverse reactions | 4 (7.27) | 7 (11.48) | 0.595 | 0.440 |